• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于宿主反应和临床因素的病毒病原体关系的网络分析:来自 SARS-CoV-2 的经验。

Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2.

机构信息

Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic.

Department of Respiratory Medicine, University Hospital, 625 00 Brno, Czech Republic.

出版信息

Viruses. 2022 Oct 31;14(11):2422. doi: 10.3390/v14112422.

DOI:10.3390/v14112422
PMID:36366522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9697085/
Abstract

Analysing complex datasets while maintaining the interpretability and explainability of outcomes for clinicians and patients is challenging, not only in viral infections. These datasets often include a variety of heterogeneous clinical, demographic, laboratory, and personal data, and it is not a single factor but a combination of multiple factors that contribute to patient characterisation and host response. Therefore, multivariate approaches are needed to analyse these complex patient datasets, which are impossible to analyse with univariate comparisons (e.g., one immune cell subset versus one clinical factor). Using a SARS-CoV-2 infection as an example, we employed a patient similarity network (PSN) approach to assess the relationship between host immune factors and the clinical course of infection and performed visualisation and data interpretation. A PSN analysis of ~85 immunological (cellular and humoral) and ~70 clinical factors in 250 recruited patients with coronavirus disease (COVID-19) who were sampled four to eight weeks after a PCR-confirmed SARS-CoV-2 infection identified a minimal immune signature, as well as clinical and laboratory factors strongly associated with disease severity. Our study demonstrates the benefits of implementing multivariate network approaches to identify relevant factors and visualise their relationships in a SARS-CoV-2 infection, but the model is generally applicable to any complex dataset.

摘要

分析复杂数据集,同时保持临床医生和患者对结果的可解释性和可理解性,这不仅在病毒感染中是具有挑战性的。这些数据集通常包含各种异质的临床、人口统计学、实验室和个人数据,导致患者特征和宿主反应的因素不是单一的,而是多种因素的组合。因此,需要采用多变量方法来分析这些复杂的患者数据集,而这些数据集是无法通过单变量比较(例如,一个免疫细胞亚群与一个临床因素)进行分析的。以 SARS-CoV-2 感染为例,我们采用患者相似性网络(PSN)方法来评估宿主免疫因素与感染临床过程之间的关系,并进行可视化和数据分析。对 250 名经 PCR 确认的 SARS-CoV-2 感染后 4 至 8 周采集的患者的约 85 个免疫(细胞和体液)和约 70 个临床因素进行 PSN 分析,确定了一个最小的免疫特征,以及与疾病严重程度强烈相关的临床和实验室因素。我们的研究表明,实施多变量网络方法来识别 SARS-CoV-2 感染中的相关因素并可视化它们之间的关系具有优势,但该模型通常适用于任何复杂数据集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7be/9697085/3787cca63853/viruses-14-02422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7be/9697085/626217e61c0c/viruses-14-02422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7be/9697085/3787cca63853/viruses-14-02422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7be/9697085/626217e61c0c/viruses-14-02422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7be/9697085/3787cca63853/viruses-14-02422-g002.jpg

相似文献

1
Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2.基于宿主反应和临床因素的病毒病原体关系的网络分析:来自 SARS-CoV-2 的经验。
Viruses. 2022 Oct 31;14(11):2422. doi: 10.3390/v14112422.
2
[Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].[对感染新冠病毒疾病并接种新冠疫苗的医护人员的新冠病毒特异性体液免疫和细胞免疫值的调查]
Mikrobiyol Bul. 2022 Jul;56(3):480-492. doi: 10.5578/mb.20229708.
3
Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.COVID-19 大流行期间西班牙大型医护人员队列中体液免疫反应的 17 个月动态:ProHEpiC-19 研究。
BMC Infect Dis. 2022 Sep 3;22(1):721. doi: 10.1186/s12879-022-07696-6.
4
SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.192 例 COVID-19 患者不同住院时间点的 SARS-CoV-2 抗体及相关因素。
J Appl Lab Med. 2021 Sep 1;6(5):1133-1142. doi: 10.1093/jalm/jfab003.
5
Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.病毒载量、感染至分娩间隔与抗 SARS-CoV-2 抗体母婴传播的关系。
Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978. doi: 10.1002/uog.23639.
6
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
7
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
8
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics.COVID-19 患者在德国选定患者队列中的血清学和病毒遗传学特征-与疾病特征的相关性。
Geroscience. 2021 Oct;43(5):2249-2264. doi: 10.1007/s11357-021-00443-w. Epub 2021 Sep 1.
9
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.一项评估褪黑素预防高危接触者 SARS-CoV-2 感染有效性的随机多中心临床试验(MeCOVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6.
10
Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.新型冠状病毒感染康复者血清特异性 IgG 抗体持久性及其与临床症状和疾病严重程度的关系:一项前瞻性纵向队列研究。
Int Immunopharmacol. 2021 Sep;98:107893. doi: 10.1016/j.intimp.2021.107893. Epub 2021 Jun 16.

本文引用的文献

1
Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.急性和恢复期 COVID-19 患者中异质性 CD8+ T 细胞的成熟和“极化”。
Viruses. 2022 Aug 28;14(9):1906. doi: 10.3390/v14091906.
2
Knee osteoarthritis phenotypes based on synovial fluid immune cells correlate with clinical outcome trajectories.基于滑液免疫细胞的膝骨关节炎表型与临床结局轨迹相关。
Osteoarthritis Cartilage. 2022 Dec;30(12):1583-1592. doi: 10.1016/j.joca.2022.08.019. Epub 2022 Sep 17.
3
Network-based integration of multi-omics data for clinical outcome prediction in neuroblastoma.
基于网络的多组学数据整合用于神经母细胞瘤的临床预后预测。
Sci Rep. 2022 Sep 14;12(1):15425. doi: 10.1038/s41598-022-19019-5.
4
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.长新冠期间 T 细胞动力学的重塑取决于 SARS-CoV-2 感染的严重程度。
Front Immunol. 2022 Jun 10;13:886431. doi: 10.3389/fimmu.2022.886431. eCollection 2022.
5
The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and Responses.新冠病毒疾病试验中同意拒绝风险增加的可能性:探究潜在原因及应对措施
Ann Am Thorac Soc. 2022 Sep;19(9):1446-1447. doi: 10.1513/AnnalsATS.202203-250VP.
6
Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.评估 COVID-19 恢复期与免疫状态变化的关联及其在患者和未感染暴露亲属中的临床严重程度。
Immunobiology. 2022 May;227(3):152216. doi: 10.1016/j.imbio.2022.152216. Epub 2022 Apr 12.
7
A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity.一项针对 COVID-19 康复者的为期 1 年的纵向研究显示,抗 SARS-CoV-2 体液和细胞免疫持续存在。
Emerg Microbes Infect. 2022 Dec;11(1):902-913. doi: 10.1080/22221751.2022.2049984.
8
Multivariate Analysis of Risk Factors of the COVID-19 Pandemic in the Community of Madrid, Spain.西班牙马德里社区新冠肺炎疫情的多因素分析。
Int J Environ Res Public Health. 2021 Sep 1;18(17):9227. doi: 10.3390/ijerph18179227.
9
Distribution of SARS-CoV-2 Lineages in the Czech Republic, Analysis of Data from the First Year of the Pandemic.捷克共和国新冠病毒谱系分布,大流行第一年数据分析
Microorganisms. 2021 Aug 5;9(8):1671. doi: 10.3390/microorganisms9081671.
10
COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters.与COVID-19相关的嗅觉丧失与人类嗅觉上皮中的病毒持续存在和炎症以及仓鼠的脑部感染有关。
Sci Transl Med. 2021 Jun 2;13(596). doi: 10.1126/scitranslmed.abf8396. Epub 2021 May 3.